323 related articles for article (PubMed ID: 7927774)
41. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
Fikrig E; Tao H; Barthold SW; Flavell RA
Infect Immun; 1995 May; 63(5):1658-62. PubMed ID: 7729870
[TBL] [Abstract][Full Text] [Related]
42. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins.
Bunikis J; Barbour AG
Infect Immun; 1999 Jun; 67(6):2874-83. PubMed ID: 10338494
[TBL] [Abstract][Full Text] [Related]
43. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
[TBL] [Abstract][Full Text] [Related]
44. Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Borrelia spp. causing Lyme disease.
Shoberg RJ; Jonsson M; Sadziene A; Bergström S; Thomas DD
J Clin Microbiol; 1994 Feb; 32(2):489-500. PubMed ID: 7512097
[TBL] [Abstract][Full Text] [Related]
45. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y
Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
[TBL] [Abstract][Full Text] [Related]
46. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
[TBL] [Abstract][Full Text] [Related]
47. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein.
Sadziene A; Jonsson M; Bergström S; Bright RK; Kennedy RC; Barbour AG
Infect Immun; 1994 May; 62(5):2037-45. PubMed ID: 7513309
[TBL] [Abstract][Full Text] [Related]
48. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
[TBL] [Abstract][Full Text] [Related]
49. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
[TBL] [Abstract][Full Text] [Related]
50. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.
Straubinger RK; Chang YF; Jacobson RH; Appel MJ
J Clin Microbiol; 1995 Oct; 33(10):2745-51. PubMed ID: 8567917
[TBL] [Abstract][Full Text] [Related]
51. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
Coughlin RT; Fish D; Mather TN; Ma J; Pavia C; Bulger P
J Infect Dis; 1995 Apr; 171(4):1049-52. PubMed ID: 7706788
[TBL] [Abstract][Full Text] [Related]
52. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.
Tai KF; Ma Y; Weis JJ
Infect Immun; 1994 Feb; 62(2):520-8. PubMed ID: 8300210
[TBL] [Abstract][Full Text] [Related]
53. Identification of Borrelia burgdorferi isolated in Korea using outer surface protein A (OspA) serotyping system.
Kee S; Hwang KJ; Oh HB; Park KS
Microbiol Immunol; 1994; 38(12):989-93. PubMed ID: 7723693
[TBL] [Abstract][Full Text] [Related]
54. Characterization of Borrelia burgdorferi sensu lato strains isolated from Ixodes ricinus in Mecklenburg-Vorpommern, Germany.
Lottmann H; Wilske B; Herrmann H
Med Microbiol Immunol; 1996 Feb; 184(4):181-4. PubMed ID: 8811650
[TBL] [Abstract][Full Text] [Related]
55. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
56. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
[TBL] [Abstract][Full Text] [Related]
57. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus.
Fingerle V; Hauser U; Liegl G; Petko B; Preac-Mursic V; Wilske B
J Clin Microbiol; 1995 Jul; 33(7):1867-9. PubMed ID: 7665661
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
Schwendinger MG; O'Rourke M; Traweger A; Savidis-Dacho H; Pilz A; Portsmouth D; Livey I; Barrett PN; Crowe BA
PLoS One; 2013; 8(11):e79022. PubMed ID: 24260146
[TBL] [Abstract][Full Text] [Related]
59. Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).
Kurtenbach K; Dizij A; Seitz HM; Margos G; Moter SE; Kramer MD; Wallich R; Schaible UE; Simon MM
Infect Immun; 1994 Dec; 62(12):5344-52. PubMed ID: 7960113
[TBL] [Abstract][Full Text] [Related]
60. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.
Hughes CA; Engstrom SM; Coleman LA; Kodner CB; Johnson RC
Infect Immun; 1993 Dec; 61(12):5115-22. PubMed ID: 8225588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
